GSE126258 GSE126739 c-Myc inhibition 1 v 0 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE126258_GSE126739_c-Myc inhibition_1_v_0_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE126258_GSE126739_c-Myc inhibition_1_v_0_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE126258_GSE126739_c-Myc inhibition_1_v_0_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE126258_GSE126739_c-Myc inhibition_1_v_0_human_up.

Results found

Linked to

 

Label

Description

 

Gene

family with sequence similarity 106 member A

Gene

Pvt1 oncogene

Gene

ZNFX1 antisense RNA 1

Gene

CASTOR family member 3, pseudogene

Gene

mir-100-let-7a-2-mir-125b-1 cluster host gene

Gene

NBPF member 26

Gene

oligodendrocyte maturation-associated long intergenic non-coding RNA

Gene

TP53 target 1

Gene

long intergenic non-protein coding RNA 3040

Gene

ATPase H+ transporting V1 subunit G2

  • Gene

    family with sequence similarity 106 member A



  • Gene

    ZNFX1 antisense RNA 1


  • Gene

    CASTOR family member 3, pseudogene


  • Gene

    mir-100-let-7a-2-mir-125b-1 cluster host gene



  • Gene

    oligodendrocyte maturation-associated long intergenic non-coding RNA



  • Gene

    long intergenic non-protein coding RNA 3040


  • Gene

    ATPase H+ transporting V1 subunit G2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.